Compare cord blood and bone marrow stem cells: collection, cell counts, HLA matching, applications, and pros/cons. Which source is right for your treatment.
Cord blood contains haematopoietic stem cells (HSCs) — the cells that replenish blood and immune cells. It is FDA-approved for over 80 blood disorders (leukaemia, sickle cell disease) and stored in public/private banks. Bone marrow-derived MSCs are harvested from the donor's own hip under general anaesthesia — painful, low-yield, and age-limited. Wharton's jelly MSCs sit in a different category: not haematopoietic, but mesenchymal — specialised for tissue repair, immune modulation, and anti-inflammatory action. For regenerative medicine applications (neurological, orthopaedic, autoimmune), WJ-MSCs are the superior source.
Private cord blood banking promises "your own stem cells for future use" — but stored cord blood HSCs cannot be used for the regenerative medicine indications most families hope for (autism, joint disease, neurological conditions). The probability of a stored unit being used for its stored child is 1:20,000–1:200,000 in childhood (ACOG estimates). WJ-MSC therapy from allogeneic GMP-certified donors delivers proven, potent neonatal-age MSCs without the 15–20 year wait or the limitations of stored HSC units.
Cord blood HSCs: best for haematological malignancies, blood disorders, and immune reconstitution. Bone marrow MSCs: autologous option when allogeneic sources are contraindicated. WJ-MSCs (allogeneic): best for regenerative medicine — neurological, autoimmune, orthopaedic, and metabolic conditions — where potency, availability, and immunomodulatory strength matter most. StemCell Longevita exclusively uses WJ-MSCs for all regenerative applications.
Related articles: Wharton's Jelly Stem Cells: Complete Guide to Umbilical Cord MSC Therapy | Types of Stem Cells Explained (2026 Update) | Mesenchymal Stem Cells (MSCs): What Every Patient Should Know
Related treatments: Autoimmune Disease Stem Cell Therapy | Cardiovascular Stem Cell Treatment | Diabetes Stem Cell Therapy